Subependymal giant cell astrocytoma physical examination: Difference between revisions
No edit summary |
|||
Line 22: | Line 22: | ||
*[[Hemiparesis]] | *[[Hemiparesis]] | ||
== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:15, 9 November 2015
Subependymal giant cell astrocytoma Microchapters |
Differentiating Subependymal Giant Cell Astrocytoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Subependymal giant cell astrocytoma physical examination On the Web |
American Roentgen Ray Society Images of Subependymal giant cell astrocytoma physical examination |
FDA on Subependymal giant cell astrocytoma physical examination |
CDC on Subependymal giant cell astrocytoma physical examination |
Subependymal giant cell astrocytoma physical examination in the news |
Blogs on Subependymal giant cell astrocytoma physical examination |
Risk calculators and risk factors for Subependymal giant cell astrocytoma physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Common physical examination findings of subependymal giant cell astrocytoma include papilledema, vision field defects, developmental delay, mental retardation, aphasia, sensory loss, and hemiparesis.[1][2]
Physical Examination
Common physical examination findings of subependymal giant cell astrocytoma include:[1][2]
HEENT
- Ophthalmoscopic exam may be abnormal with findings such as:
Neurological
References
- ↑ 1.0 1.1 Sasongko, Teguh Haryo; Ismail, Nur Farrah Dila; Nik Abdul Malik, Nik Mohamad Ariff; Zabidi-Hussin, Z. A. M. H. (2015). "Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis". Orphanet Journal of Rare Diseases. 10 (1). doi:10.1186/s13023-015-0317-7. ISSN 1750-1172.
- ↑ 2.0 2.1 Ouyang, Taohui; Zhang, Na; Benjamin, Thomas; Wang, Long; Jiao, Jiantong; Zhao, Yiqing; Chen, Jian (2014). "Subependymal giant cell astrocytoma: current concepts, management, and future directions". Child's Nervous System. 30 (4): 561–570. doi:10.1007/s00381-014-2383-x. ISSN 0256-7040.